March 29, 2019
AlphaNavi President and CEO Yoshihiro Oyamada Sumitomo Dainippon Pharma and Kyoto University Innovation Capital said on March 28 that they have formed a new company by carving out the Osaka-based drug maker’s non-core pain program, DSP-2230, in a bid to...read more